The Silver-Russell syndrome market reached a value of USD 393.6 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top... Read More
Author: marketreport
The autoimmune hepatitis market reached a value of USD 118.6 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top... Read More
The chronic myeloid leukemia market reached a value of USD 5.7 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the... Read More
The report also provides a detailed analysis of the current Ornithine Transcarbamylase Deficiency marketed drugs and late-stage pipeline drugs. The escalating prevalence of mutations in the OTC gene that can... Read More
According to report by IMARC Group, the report provides the key factors driving the advancement in treatment of Neurofibromatosis Type 1. Increased incidence of NF1 and increased awareness about its... Read More